Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-25 @ 9:02 PM
Study NCT ID:
NCT05798156
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-02
First Post:
2023-03-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-08
First Submit QC Date:
None
Study First Post Date:
2023-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-29
Last Update Post Date:
2025-05-02
Last Update Post Date Type:
ACTUAL